BIOMAT Database Logo BIOMAT Database Logo

Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies? 2017

Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Aix Marseille University, INSERM, VRCM, UMR_S 1076, Marseille, France; APHM, Hôpital Nord, Médecine interne, Marseille, France. Electronic address: Audrey.benyamine@ap-hm.fr.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002503 Centromere The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Centromeres
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Anti-RNA polymerase antibodies in systemic sclerosis (SSc): association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II.
September 1996, Clinical and experimental immunology,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
July 2011, The Journal of rheumatology,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
[Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
January 2018, Annales de dermatologie et de venereologie,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Paraneoplastic Systemic Sclerosis: Focus on Anti-RNA Polymerase III Antibodies.
January 2016, Skinmed,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
April 2020, Clinical rheumatology,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
February 2015, The Journal of dermatology,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Anti-RNA polymerase III antibodies in systemic sclerosis: Multicentric study from Argentina.
January 2022, Reumatologia clinica,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: Multicentric Study from Argentina.
April 2021, Reumatologia clinica,
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA.
July 2008, Rheumatology (Oxford, England),
Audrey Benyamine, and Daniel Bertin, and Xavier Heim, and Brigitte Granel, and Nathalie Bardin
Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.
October 2018, Journal of scleroderma and related disorders,
Copied contents to your clipboard!